Tower Research Capital LLC (Trc) Hcw Biologics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,938 shares of HCWB stock, worth $3,209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,938
Previous 5,669
12.89%
Holding current value
$3,209
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HCWB
# of Institutions
21Shares Held
1.1MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL180KShares$116,8760.0% of portfolio
-
Avantax Planning Partners, Inc.180KShares$116,8550.01% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$113,2840.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$85,7930.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL85.1KShares$55,3250.13% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $23.3M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...